Literature DB >> 30202322

Performance-Enhancing Drug Use in Adolescence.

Nicole D White1, James Noeun1.   

Abstract

Despite inconclusive efficacy data and concerning safety data, the use of performance-enhancing drugs (PEDs) in the adolescent population is on the rise. Anabolic-androgenic steroids, growth hormones, stimulants, and erythropoiesis-stimulating agents are among the most widely known and studied prescription PEDs in the adolescent population. The purpose of this article is to describe the proposed mechanism of action, efficacy and adverse effects of these agents as well as discuss prevention measures and treatment considerations for those patients at risk for, considering, or currently using PEDs.

Entities:  

Keywords:  adolescent; doping; performance enhancing drugs

Year:  2016        PMID: 30202322      PMCID: PMC6125030          DOI: 10.1177/1559827616680593

Source DB:  PubMed          Journal:  Am J Lifestyle Med        ISSN: 1559-8276


  17 in total

1.  Use of performance-enhancing substances.

Authors:  Jorge Gomez
Journal:  Pediatrics       Date:  2005-04       Impact factor: 7.124

2.  Nutritional supplementation and anabolic steroid use in adolescents.

Authors:  Jay R Hoffman; Avery D Faigenbaum; Nicholas A Ratamess; Ryan Ross; Jie Kang; Gershon Tenenbaum
Journal:  Med Sci Sports Exerc       Date:  2008-01       Impact factor: 5.411

3.  Stimulants in sports.

Authors:  E Randy Eichner
Journal:  Curr Sports Med Rep       Date:  2008 Sep-Oct       Impact factor: 1.733

Review 4.  Use of doping agents, particularly anabolic steroids, in sports and society.

Authors:  Folke Sjöqvist; Mats Garle; Anders Rane
Journal:  Lancet       Date:  2008-05-31       Impact factor: 79.321

5.  Adolescent drug testing policies in schools.

Authors:  Sharon Levy; Miriam Schizer
Journal:  Pediatrics       Date:  2015-04       Impact factor: 7.124

Review 6.  Systematic review: the effects of growth hormone on athletic performance.

Authors:  Hau Liu; Dena M Bravata; Ingram Olkin; Anne Friedlander; Vincent Liu; Brian Roberts; Eran Bendavid; Olga Saynina; Shelley R Salpeter; Alan M Garber; Andrew R Hoffman
Journal:  Ann Intern Med       Date:  2008-03-17       Impact factor: 25.391

Review 7.  Erythropoiesis-stimulating agents and other methods to enhance oxygen transport.

Authors:  S Elliott
Journal:  Br J Pharmacol       Date:  2008-03-24       Impact factor: 8.739

8.  Popular ergogenic drugs and supplements in young athletes.

Authors:  Ryan Calfee; Paul Fadale
Journal:  Pediatrics       Date:  2006-03       Impact factor: 7.124

9.  Physical effects of short-term recombinant human growth hormone administration in abstinent steroid dependency.

Authors:  Michael R Graham; Julien S Baker; Peter Evans; Andrew Kicman; David Cowan; David Hullin; Non Thomas; Bruce Davies
Journal:  Horm Res       Date:  2008-03-17

10.  Short-term recombinant human growth hormone administration improves respiratory function in abstinent anabolic-androgenic steroid users.

Authors:  Michael R Graham; Julien S Baker; Peter Evans; Andrew Kicman; David Cowan; David Hullin; Bruce Davies
Journal:  Growth Horm IGF Res       Date:  2007-05-23       Impact factor: 2.372

View more
  1 in total

Review 1.  Anabolic Androgenic Steroids: Searching New Molecular Biomarkers.

Authors:  Francesco Sessa; Monica Salerno; Giulio Di Mizio; Giuseppe Bertozzi; Giovanni Messina; Benedetta Tomaiuolo; Daniela Pisanelli; Francesca Maglietta; Pietrantonio Ricci; Cristoforo Pomara
Journal:  Front Pharmacol       Date:  2018-11-20       Impact factor: 5.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.